drugset / Trial / NCT01325571

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

NCT01325571

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of tacrolimus capsules in patients with myasthenia gravis who are inadequately treated by glucocorticoid.

Timeline

Start
2011-03
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 3 mg Oral

Indications